Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant FOLFOX4 for HCC with PVTT
NCT02813096Phase 3Unknown
- Sponsor
- Guangxi Medical University
- Start
- Oct 2016
- Primary completion
- Jul 2018
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
01
Overview
A Phase 3 trial of oxaliplatin, folinic acid, fluorouracil in hepatocellular carcinoma (HCC), sponsored by Guangxi Medical University. Status: unknown.
02
Drugs
oxaliplatinfolinic acidfluorouracil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02813096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02813096.